- What is daclizumab, and how does it work?
- What brand names are available for daclizumab?
- Is daclizumab available as a generic drug?
- Do I need a prescription for daclizumab?
- What are the uses for daclizumab?
- Why is there a black box warning for daclizumab?
- What are the side effects of daclizumab?
- What is the dosage for daclizumab?
- Which drugs or supplements interact with daclizumab?
- Is daclizumab safe to use during pregnancy or while breastfeeding?
- What else should I know about daclizumab?
What is daclizumab, and how does it work?
- Daclizumab (Zinbryta) is an injectable medication used for treating multiple sclerosis (MS). Its mechanism of action is not completely understood. Available data suggests that it may work by modifying immune processes that may be responsible for causing MS by interfering with the activation of lymphocytes (a type of white blood cell) that cause inflammation and destruction of nerves in patients with MS. Daclizumab does not cure MS. It decreases the number of MS flares and lesions.
- The FDA approved daclizumab in May, 2016.
What brand names are available for daclizumab?
- Zinbryta is the brand name for daclizumab available in the US.
Quick GuideMultiple Sclerosis (MS) Symptoms and Treatment
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.